Alice Turdo

1.9k total citations
29 papers, 1.1k citations indexed

About

Alice Turdo is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Alice Turdo has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Alice Turdo's work include Cancer Cells and Metastasis (11 papers), Epigenetics and DNA Methylation (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Alice Turdo is often cited by papers focused on Cancer Cells and Metastasis (11 papers), Epigenetics and DNA Methylation (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Alice Turdo collaborates with scholars based in Italy, Argentina and Germany. Alice Turdo's co-authors include Matilde Todaro, Giorgio Stassi, Simone Di Franco, Francesco Dieli, Veronica Catalano, Miriam Gaggianesi, Aurora Chinnici, Veronica Veschi, Paola Bianca and Gaetana Porcelli and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Alice Turdo

29 papers receiving 1.1k citations

Peers

Alice Turdo
Alice Turdo
Citations per year, relative to Alice Turdo Alice Turdo (= 1×) peers Alessandra Boe

Countries citing papers authored by Alice Turdo

Since Specialization
Citations

This map shows the geographic impact of Alice Turdo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alice Turdo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alice Turdo more than expected).

Fields of papers citing papers by Alice Turdo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alice Turdo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alice Turdo. The network helps show where Alice Turdo may publish in the future.

Co-authorship network of co-authors of Alice Turdo

This figure shows the co-authorship network connecting the top 25 collaborators of Alice Turdo. A scholar is included among the top collaborators of Alice Turdo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alice Turdo. Alice Turdo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lago, Sara, Vittoria Poli, Alice Turdo, et al.. (2025). ANP32E drives vulnerability to ATR inhibitors by inducing R-loops-dependent transcription replication conflicts in triple negative breast cancer. Nature Communications. 16(1). 4602–4602. 1 indexed citations
2.
Gaggianesi, Miriam, Gaetana Porcelli, Alice Turdo, et al.. (2025). A Novel Tumor on Chip Mimicking the Breast Cancer Microenvironment for Dynamic Drug Screening. International Journal of Molecular Sciences. 26(3). 1028–1028. 4 indexed citations
3.
Turdo, Alice, Sebastiano Di Bella, Gaetana Porcelli, et al.. (2025). Heightened IDO1 levels predict Bacillus Calmette-Guèrin failure in high-risk non-muscle-invasive bladder cancer patients. Cell Death Discovery. 11(1). 203–203. 1 indexed citations
4.
Turdo, Alice, Miriam Gaggianesi, Gaetana Porcelli, et al.. (2023). EBF1, MYO6 and CALR expression levels predict therapeutic response in diffuse large B-cell lymphomas. Frontiers in Immunology. 14. 1266265–1266265. 3 indexed citations
5.
Veschi, Veronica, Alice Turdo, & Giorgio Stassi. (2023). Novel insights into cancer stem cells targeting: CAR-T therapy and epigenetic drugs as new pillars in cancer treatment. SHILAP Revista de lepidopterología. 3. 1120090–1120090. 5 indexed citations
6.
Iacono, Melania Lo, Miriam Gaggianesi, Paola Bianca, et al.. (2022). Destroying the Shield of Cancer Stem Cells: Natural Compounds as Promising Players in Cancer Therapy. Journal of Clinical Medicine. 11(23). 6996–6996. 10 indexed citations
7.
Gaggianesi, Miriam, Laura Rosa Mangiapane, Chiara Modica, et al.. (2022). Dual Inhibition of Myc Transcription and PI3K Activity Effectively Targets Colorectal Cancer Stem Cells. Cancers. 14(3). 673–673. 6 indexed citations
8.
Iacono, Melania Lo, Chiara Modica, Gaetana Porcelli, et al.. (2022). Targeting of the Peritumoral Adipose Tissue Microenvironment as an Innovative Antitumor Therapeutic Strategy. Biomolecules. 12(5). 702–702. 12 indexed citations
9.
Pagliari, Francesca, Elisa Sogne, Gerardo Perozziello, et al.. (2022). Correlative Raman–Electron–Light (CREL) Microscopy Analysis of Lipid Droplets in Melanoma Cancer Stem Cells. Biosensors. 12(12). 1102–1102. 3 indexed citations
10.
Modica, Chiara, Gaetana Porcelli, Alice Turdo, et al.. (2022). Targeting epigenetic alterations in cancer stem cells. SHILAP Revista de lepidopterología. 2. 1011882–1011882. 14 indexed citations
11.
Sorrentino, Carlo, et al.. (2021). Interleukin-30 feeds breast cancer stem cells via CXCL10 and IL23 autocrine loops and shapes immune contexture and host outcome. Journal for ImmunoTherapy of Cancer. 9(10). e002966–e002966. 21 indexed citations
12.
Turdo, Alice, Antonino Glaviano, Gaetana Porcelli, et al.. (2021). Targeting Phosphatases and Kinases: How to Checkmate Cancer. Frontiers in Cell and Developmental Biology. 9. 690306–690306. 36 indexed citations
13.
Veschi, Veronica, Melania Lo Iacono, Gaetana Porcelli, et al.. (2020). Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis. Frontiers in Endocrinology. 11. 566–566. 29 indexed citations
14.
Poli, Vittoria, Luca Fagnocchi, Alessandra Fasciani, et al.. (2018). MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state. Nature Communications. 9(1). 1024–1024. 107 indexed citations
15.
Presti, Elena Lo, Francesca Toia, Simona Buccheri, et al.. (2017). Squamous Cell Tumors Recruit γδ T Cells Producing either IL17 or IFNγ Depending on the Tumor Stage. Cancer Immunology Research. 5(5). 397–407. 68 indexed citations
16.
Gaggianesi, Miriam, Alice Turdo, Aurora Chinnici, et al.. (2017). IL4 Primes the Dynamics of Breast Cancer Progression via DUSP4 Inhibition. Cancer Research. 77(12). 3268–3279. 48 indexed citations
17.
Franco, Simone Di, Alice Turdo, Matilde Todaro, & Giorgio Stassi. (2017). Role of Type I and II Interferons in Colorectal Cancer and Melanoma. Frontiers in Immunology. 8. 878–878. 59 indexed citations
18.
Cola, Antonella De, Silvia Volpe, Maria Cristina Budani, et al.. (2015). miR-205-5p-mediated downregulation of ErbB/HER receptors in breast cancer stem cells results in targeted therapy resistance. Cell Death and Disease. 6(7). e1823–e1823. 73 indexed citations
19.
Todaro, Matilde, Alice Turdo, Monica Bartucci, et al.. (2013). Erythropoietin Activates Cell Survival Pathways in Breast Cancer Stem–like Cells to Protect Them from Chemotherapy. Cancer Research. 73(21). 6393–6400. 41 indexed citations
20.
Catalano, Veronica, Alice Turdo, Simone Di Franco, et al.. (2013). Tumor and its microenvironment: A synergistic interplay. Seminars in Cancer Biology. 23(6). 522–532. 349 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026